Literature DB >> 14500254

Murine complement interactions with Pseudomonas aeruginosa and their consequences during pneumonia.

John G Younger1, Sunita Shankar-Sinha, Marc Mickiewicz, Adam S Brinkman, Gabriel A Valencia, J Vidya Sarma, Ellen M Younkin, Theodore J Standiford, Firas S Zetoune, Peter A Ward.   

Abstract

Complement is necessary for defense against lung infection with Pseudomonas aeruginosa in mice. We studied in vitro interactions between complement and P. aeruginosa and in vivo effects of complement depletion to better understand this relationship. In vitro, P. aeruginosa strain UI-18 was resistant to killing by mouse serum. However, C3 opsonized the organism (via the alternative and mannose binding lectin [MBL] pathways), and C5 convertase activity on the bacterial surface was demonstrated. In vivo, compared with normal mice, complement-deficient mice experienced higher mortality and failed to sterilize their bronchoalveolar space within 24 h of inoculation. These changes did not seem to be a result of decreased inflammation because complement-deficient mice had normal neutrophil recruitment, greater lung myeloperoxidase content, and, by 24 h, a 35-fold higher level of the CXC chemokine KC. Lung static pressure-volume curves were abnormal in infected animals but were significantly more so in complement deficient mice. These data indicate that although P. aeruginosa is resistant to serum killing, C3 opsonization and C5 convertase assembly occur on its surface. This interaction in vivo plays a central role in host survival beyond just recruitment and activation of phagocytes and may serve to limit the inflammatory response to and tissue injury resulting from bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500254      PMCID: PMC4153788          DOI: 10.1165/rcmb.2002-0145OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  19 in total

1.  Systemic and lung physiological changes in rats after intravascular activation of complement.

Authors:  J G Younger; N Sasaki; J Delgado; A C Ko; T X Nghiem; M D Waite; G O Till; P A Ward
Journal:  J Appl Physiol (1985)       Date:  2001-06

2.  The effect of complement depletion on lung clearance of bacteria.

Authors:  G N Gross; S R Rehm; A K Pierce
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

3.  CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia.

Authors:  W C Tsai; R M Strieter; B Mehrad; M W Newstead; X Zeng; T J Standiford
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Protective effects of C5a blockade in sepsis.

Authors:  B J Czermak; V Sarma; C L Pierson; R L Warner; M Huber-Lang; N M Bless; H Schmal; H P Friedl; P A Ward
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

5.  Partial liquid ventilation protects lung during resuscitation from shock.

Authors:  J G Younger; A S Taqi; G O Till; R B Hirschl
Journal:  J Appl Physiol (1985)       Date:  1997-11

6.  Complement-mediated host defense in the lung.

Authors:  W T Watford; A J Ghio; J R Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-11       Impact factor: 5.464

7.  Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis.

Authors:  P Garred; T Pressler; H O Madsen; B Frederiksen; A Svejgaard; N Høiby; M Schwartz; C Koch
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

8.  Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.

Authors:  M F Tosi; H Zakem; M Berger
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

9.  Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.

Authors:  J C Fitch; S Rollins; L Matis; B Alford; S Aranki; C D Collard; M Dewar; J Elefteriades; R Hines; G Kopf; P Kraker; L Li; R O'Hara; C Rinder; H Rinder; R Shaw; B Smith; G Stahl; S K Shernan
Journal:  Circulation       Date:  1999 Dec 21-28       Impact factor: 29.690

10.  Complement receptor 1/CD35 is a receptor for mannan-binding lectin.

Authors:  I Ghiran; S F Barbashov; L B Klickstein; S W Tas; J C Jensenius; A Nicholson-Weller
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more
  21 in total

Review 1.  Innate immune responses to Pseudomonas aeruginosa infection.

Authors:  Elise G Lavoie; Tamding Wangdi; Barbara I Kazmierczak
Journal:  Microbes Infect       Date:  2011-08-02       Impact factor: 2.700

Review 2.  Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection.

Authors:  Christina K Lin; Barbara I Kazmierczak
Journal:  J Innate Immun       Date:  2017-02-22       Impact factor: 7.349

3.  Overexpression of MexCD-OprJ reduces Pseudomonas aeruginosa virulence by increasing its susceptibility to complement-mediated killing.

Authors:  Inmaculada Martínez-Ramos; Xavier Mulet; Bartolomé Moyá; Mariette Barbier; Antonio Oliver; Sebastián Albertí
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

4.  Dynamics of intrapulmonary bacterial growth in a murine model of repeated microaspiration.

Authors:  Itzhak Ben-David; Sarah E Price; David M Bortz; Colin F Greineder; Samuel E Cohen; Amy L Bauer; Trachette L Jackson; John G Younger
Journal:  Am J Respir Cell Mol Biol       Date:  2005-07-13       Impact factor: 6.914

5.  Complement C5 and early oxygen kinetics during murine sepsis.

Authors:  Gabriel Valencia; J Vidya Sarma; John G Younger
Journal:  Acad Emerg Med       Date:  2005-04       Impact factor: 3.451

6.  Identification of OprF as a complement component C3 binding acceptor molecule on the surface of Pseudomonas aeruginosa.

Authors:  Meenu Mishra; Adam Ressler; Larry S Schlesinger; Daniel J Wozniak
Journal:  Infect Immun       Date:  2015-05-11       Impact factor: 3.441

7.  Spatiotemporal dynamics of complement C5a production within bacterial extracellular polymeric substance.

Authors:  Erin C Conrad; Yueh-Ya Hsu; David M Bortz; John G Younger
Journal:  J Innate Immun       Date:  2013-01-11       Impact factor: 7.349

8.  Dynamics of human complement-mediated killing of Klebsiella pneumoniae.

Authors:  Christina M Nypaver; Margaret M Thornton; Suellen M Yin; David O Bracho; Patrick W Nelson; Alan E Jones; David M Bortz; John G Younger
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-11       Impact factor: 6.914

9.  Complement c5a generation by staphylococcal biofilms.

Authors:  Ashley E Satorius; Jacob Szafranski; Derek Pyne; Mahesh Ganesan; Michael J Solomon; Duane W Newton; David M Bortz; John G Younger
Journal:  Shock       Date:  2013-04       Impact factor: 3.454

10.  The Klebsiella pneumoniae O antigen contributes to bacteremia and lethality during murine pneumonia.

Authors:  Sunita Shankar-Sinha; Gabriel A Valencia; Brian K Janes; Jessica K Rosenberg; Chris Whitfield; Robert A Bender; Ted J Standiford; John G Younger
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.